The aggravatory effect of nicotine on Helicobacter pylori-induced gastric mucosa injury: Role of asymmetric dimethylarginine

Journal of Clinical Gastroenterology

Volumn 43, Issue 3, 2009, Pages 261-266

  Zhang, Zhe ^a   Zou, Yi You ^a   Zhou, Yuan ^a   Zhou, Hui ^a   Li, Yuan Jian ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Apoptosis; Asymmetric dimethylarginine (ADMA); H. pylori; Nicotine; Smoking

Indexed keywords

N(G),N(G) DIMETHYLARGININE; NICOTINE;

ADULT; APOPTOSIS; ARTICLE; DISEASE EXACERBATION; FEMALE; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PLASMA; PRIORITY JOURNAL; RISK FACTOR; SMOKING; STOMACH EPITHELIUM; STOMACH INJURY; STOMACH JUICE; STOMACH MUCOSA;

ADOLESCENT; ADULT; APOPTOSIS; ARGININE; CELLS, CULTURED; FEMALE; GASTRIC JUICE; GASTRIC MUCOSA; GASTRITIS; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; NICOTINE; NITRIC OXIDE; STOMACH ULCER; YOUNG ADULT;

EID: 67650860236     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181624485     Document Type: Article

References (46)

1. Berg A, Kechagias S, Sjostrand SE, et al. Morphological support for paracrine inhibition of gastric acid secretion by nitric oxide in humans. Scand J Gastroenterol. 2001;36: 1016-1021. (Pubitemid 32801684)
2. Isenberg JS, Hyodo F, Matsumoto K, et al. Thrombospondin- 1 limits ischemic tissue survival by inhibiting nitric oxidemediated vascular smooth muscle relaxation. Blood. 2007;109: 1945-1952. (Pubitemid 46348191)
3. Buchwalow IB, Podzuweit T, Bocker W, et al. Vascular smooth muscle and nitric oxide synthase. FASEB J. 2002;16: 500-508. (Pubitemid 34273233)
4. Cawley SM, Sawyer CL, Brunelle KF, et al. Nitric oxideevoked transient kinetics of cyclic GMP in vascular smooth muscle cells. Cell Signal. 2007;19:1023-1033.
5. MacNaughton WK, Cirino G, Wallace JL. Endotheliumderived relaxing factor (nitric oxide) has protective actions in the stomach. Life Sci. 1989;45:1869-1876. (Pubitemid 19284677)
6. Qui BS, Mei QB, Liu L, et al. Effects of nitric oxide on gastric ulceration induced by nicotine and cold-restraint stress. World J Gastroenterol. 2004;10:594-597. (Pubitemid 38325322)
7. Ma JJ, Hou DQ, Zhang QB, et al. Reversal of the gastric effects of nicotine by nitric oxide donor treatment. Digestion. 2001;63:102-107. (Pubitemid 32221203)
8. Tran CT, Leiper JM, Vallance P. The DDAH/ADMA/NOS pathway. Atheroscler Suppl. 2003;4:33-40.
9. Sydow K, Munzel T. ADMA and oxidative stress. Atheroscler Suppl. 2003;4:41-51.
10. Suda O, Tsutsui M, Morishita T, et al. Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress. Arterioscler Thromb Vasc Biol. 2004;24:1682-1688. (Pubitemid 39180895)
11. Boger RH, Schwedhelm E, Maas R, et al. ADMA and oxidative stress may relate to the progression of renal disease: rationale and design of the VIVALDI study. Vasc Med. 2005; 10(suppl 1):S97-S102. (Pubitemid 43137273)
12. Jiang DJ, Jia SJ, Dai Z, et al. Asymmetric dimethylarginine induces apoptosis via p38 MAPK/caspase-3-dependent signaling pathway in endothelial cells. J Mol Cell Cardiol. 2006;40:529-539.
13. Yuan Q, Jiang DJ, Chen QQ, et al. Role of asymmetric dimethylarginine in homocysteine-induced apoptosis of vascular smooth muscle cells. Biochem Biophys Res Commun. 2007; 356:880-885. (Pubitemid 46529375)
14. Jiang JL, Wang S, Li NS, et al. The inhibitory effect of simvastatin on the ADMA-induced inflammatory reaction is mediated by MAPK pathways in endothelial cells. Biochem Cell Biol. 2007;85:66-77. (Pubitemid 46877389)
15. Krzyzanowska K, Mittermayer F, Shnawa N, et al. Asymmetrical dimethylarginine is related to renal function, chronic inflammation and macroangiopathy in patients with type 2 diabetes and albuminuria. Diabet Med. 2007;24:81-86. (Pubitemid 46103075)
16. Jiang DJ, Jia SJ, Yan J, et al. Involvement of DDAH/ADMA/ NOS pathway in nicotine-induced endothelial dysfunction. Biochem Biophys Res Commun. 2006;349:683-693. (Pubitemid 44344570)
17. Boger RH. Association of asymmetric dimethylarginine and endothelial dysfunction. Clin Chem Lab Med. 2003;41: 1467-1472. (Pubitemid 37493562)
18. Yin QF, Fu SH, He P, et al. Dimethylarginine dimethylaminohydrolase inhibition and asymmetric dimethylarginine accumulation contribute to endothelial dysfunction in rats exposed to glycosylated protein: effects of aminoguanidine. Atherosclerosis. 2007;190:53-61. (Pubitemid 44908321)
19. Tan B, Jiang DJ, Huang H, et al. Taurine protects against low-density lipoprotein-induced endothelial dysfunction by the DDAH/ADMA pathway. Vascul Pharmacol. 2007;46:338-345. (Pubitemid 46386501)
20. Marra M, Bonfigli AR, Bonazzi P, et al. Asymptomatic Helicobacter pylori infection increases asymmetric dimethylarginine levels in healthy subjects. Helicobacter. 2005;10:609-614. (Pubitemid 41668346)
21. Enarsson K, Brisslert M, Backert S, et al. Helicobacter pylori induces transendothelial migration of activated memory T cells. Infect Immun. 2005;73:761-769. (Pubitemid 40165731)
22. Hirata Y, Maeda S, Ohmae T, et al. Helicobacter pylori induces IkappaB kinase alpha nuclear translocation and chemokine production in gastric epithelial cells. Infect Immun. 2006;74: 1452-1461. (Pubitemid 43346777)
23. Expert committee on the diagnosis and classification of diabetes mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183-1197.
24. Tepperman BL, Soper BD. Nitric oxide synthase induction and cytoprotection of rat gastric mucosa from injury by ethanol. Can J Physiol Pharmacol. 1994;72:1308-1312.
25. Elesber AA, Solomon H, Lennon RJ, et al. Coronary endothelial dysfunction is associated with erectile dysfunction and elevated asymmetric dimethylarginine in patients with early atherosclerosis. Eur Heart J. 2006;27:824-831.
26. Yu XJ, Li YJ, Xiong Y. Increase of an endogenous inhibitor of nitric oxide synthesis in serum of high cholesterol fed rabbits. Life Sci. 1994;54:753-758. (Pubitemid 24095592)
27. Okubo K, Hayashi K, Wakino S, et al. Role of asymmetrical dimethylarginine in renal microvascular endothelial dysfunction in chronic renal failure with hypertension. Hypertens Res. 2005;28:181-189. (Pubitemid 40663070)
28. Maas R. Pharmacotherapies and their influence on asymmetric dimethylargine (ADMA). VascMed. 2005;10(suppl 1):S49-S57. (Pubitemid 43137268)
29. Delles C, Schneider MP, John S, et al. Angiotensin converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical N(G), N(G)-dimethylarginine in human essential hypertension. Am J Hypertens. 2002; 15:590-593. (Pubitemid 34734805)
30. Jia SJ, Jiang DJ, Hu CP, et al. Lysophosphatidylcholineinduced elevation of asymmetric dimethylarginine level by the NADPH oxidase pathway in endothelial cells. Vascul Pharmacol. 2006;44:143-148.
31. Augusto AC, Miguel F, Mendonca S, et al. Oxidative stress expression status associated to Helicobacter pylori virulence in gastric diseases. Clin Biochem. 2007;40:615-622. (Pubitemid 46829080)
32. Pignatelli B, Bancel B, Plummer M, et al. Helicobacter pylori eradication attenuates oxidative stress in human gastric mucosa. Am J Gastroenterol. 2001;96:1758-1766. (Pubitemid 32552356)
33. Keenan JI, Peterson RA, Hampton MB. NADPH oxidase involvement in the pathology of Helicobacter pylori infection. Free Radic Biol Med. 2005;38:1188-1196.
34. Wadstrom T, Rydberg J, Rozalska B, et al. Intravenous Helicobacter pylori induces low levels of TNF-alpha and IL-1 alpha in a murine model. APMIS. 1994;102:49-52. (Pubitemid 24118944)
35. Eid HM, Lyberg T, Arnesen H, et al. Insulin and adiponectin inhibit the TNF alpha-induced ADMA accumulation in human endothelial cells the role of DDAH. Atherosclerosis. 2007;194:e1-e8. (Pubitemid 47513102)
36. Sontag S, Graham DY, Belsito A, et al. Cimetidine, cigarette smoking, and recurrence of duodenal ulcer. N Engl J Med. 1984;311:689-693. (Pubitemid 14074553)
37. Kikendall JW, Evaul J, Johnson LF. Effect of cigarette smoking on gastrointestinal physiology and non-neoplastic digestive disease. J Clin Gastroenterol. 1984;6:65-79. (Pubitemid 14184754)
38. Husain K, Scott BR, Reddy SK, et al. Chronic ethanol and nicotine interaction on rat tissue antioxidant defense system. Alcohol. 2001;25:89-97. (Pubitemid 34016034)
39. Miller VM, Clouse WD, Tonnessen BH, et al. Time and dose effect of transdermal nicotine on endothelial function. Am J Physiol Heart Circ Physiol. 2000;279:H1913-H1921.
40. McGee DJ, Mobley HL. Pathogenesis of Helicobacter pylori infection. Curr Opin Gastroenterol. 2000;16:24-31.
41. Hirasawa R, Tatsuta M, Iishi H, et al. Increase in apoptosis and decrease in ornithine decarboxylase activity of the gastric mucosa in patients with atrophic gastritis and gastric ulcer after successful eradication of Helicobacter pylori. Am J Gastroenterol. 1999;94:2398-2402. (Pubitemid 29420663)
42. Kohda K, Tanaka K, Aiba Y, et al. Role of apoptosis induced by Helicobacter pylori infection in the development of duodenal ulcer. Gut. 1999;44:456-462. (Pubitemid 29169943)
43. Boger RH, Bode-Boger SM, Tsao PS, et al. An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes. J Am Coll Cardiol. 2000;36: 2287-2295.
44. Chen MF, Xie XM, Yang TL, et al. Role of asymmetric dimethylarginine in inflammatory reactions by angiotensin II. J Vasc Res. 2007;44:391-402. (Pubitemid 47312660)
45. Jiang JL, Jiang DJ, Tang YH, et al. Effect of simvastatin on endothelium-dependent vaso-relaxation and endogenous nitric oxide synthase inhibitor. Acta Pharmacol Sin. 2004;25: 893-901. (Pubitemid 38915447)
46. Deng S, Deng PY, Jiang JL, et al. Aspirin protected against endothelial damage induced by LDL: role of endogenous NO synthase inhibitors in rats. Acta Pharmacol Sin. 2004;25: 1633-1639. (Pubitemid 39628031)